Bruce H Mandt1, Leland I Copenhagen2, Nancy R Zahniser3, Richard M Allen2. 1. Department of Psychology, University of Colorado Denver, Denver, CO 80217, United States. Electronic address: bruce.mandt@ucdenver.edu. 2. Department of Psychology, University of Colorado Denver, Denver, CO 80217, United States. 3. Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, United States.
Abstract
BACKGROUND: Escalation of consumption is a hallmark of cocaine addiction. Many animal models reveal escalation by increasing the duration of drug access (e.g., 6-24 h/day) after longer histories of self-administration. We recently developed a method that reveals escalation early post-acquisition under shorter access conditions. However, whether or not rats will escalate cocaine consumption both early post-acquisition under short access (2 h/day) conditions, and later under long access (6 h/day) conditions, has not been demonstrated. METHODS: All rats acquired cocaine self-administration (0.8 mg/kg, i.v.) under 2 h conditions, and then continued 2h self-administration for an additional 13 sessions. Then, rats were assigned either to 2 or 6h conditions, and self-administered cocaine (0.8 mg/kg, i.v.) for an additional 19 sessions. In addition, four cocaine-induced locomotor activity measurements were taken for each rat: before cocaine exposure, after non-contingent cocaine administration, and after escalation in the short and long access experimental phases. RESULTS: Following acquisition, rats displayed a robust escalation of intake during 2 h sessions. Rats that self-administered cocaine in continued 2h sessions exhibited stable intake, whereas rats that self-administered cocaine in 6h sessions further escalated intake. Despite the second escalation in 6h rats, cocaine-induced locomotor activity did not differ between 2 and 6h rats. CONCLUSIONS: Escalation of cocaine self-administration can occur in the same rats both early post-acquisition, and later under long access conditions. Importantly, this early post-acquisition period provides a new opportunity to determine the mechanisms first involved in the escalation phenomenon.
BACKGROUND: Escalation of consumption is a hallmark of cocaine addiction. Many animal models reveal escalation by increasing the duration of drug access (e.g., 6-24 h/day) after longer histories of self-administration. We recently developed a method that reveals escalation early post-acquisition under shorter access conditions. However, whether or not rats will escalate cocaine consumption both early post-acquisition under short access (2 h/day) conditions, and later under long access (6 h/day) conditions, has not been demonstrated. METHODS: All rats acquired cocaine self-administration (0.8 mg/kg, i.v.) under 2 h conditions, and then continued 2h self-administration for an additional 13 sessions. Then, rats were assigned either to 2 or 6h conditions, and self-administered cocaine (0.8 mg/kg, i.v.) for an additional 19 sessions. In addition, four cocaine-induced locomotor activity measurements were taken for each rat: before cocaine exposure, after non-contingent cocaine administration, and after escalation in the short and long access experimental phases. RESULTS: Following acquisition, rats displayed a robust escalation of intake during 2 h sessions. Rats that self-administered cocaine in continued 2h sessions exhibited stable intake, whereas rats that self-administered cocaine in 6h sessions further escalated intake. Despite the second escalation in 6h rats, cocaine-induced locomotor activity did not differ between 2 and 6h rats. CONCLUSIONS: Escalation of cocaine self-administration can occur in the same rats both early post-acquisition, and later under long access conditions. Importantly, this early post-acquisition period provides a new opportunity to determine the mechanisms first involved in the escalation phenomenon.
Authors: Leigh V Panlilio; Jonathan L Katz; Roy W Pickens; Charles W Schindler Journal: Psychopharmacology (Berl) Date: 2003-03-18 Impact factor: 4.530
Authors: Kyle L Ploense; Philip Vieira; Lana Bubalo; Gema Olivarria; Amanda E Carr; Karen K Szumlinski; Tod E Kippin Journal: Psychopharmacology (Berl) Date: 2017-12-12 Impact factor: 4.530
Authors: Caitlin A Orsini; Shelby L Blaes; Richard J Dragone; Sara M Betzhold; Alyssa M Finner; Jennifer L Bizon; Barry Setlow Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2019-10-30 Impact factor: 5.067